Dr. David H. Henry III, MD
Hematology & Oncology (Hematology & Oncology Physician)
- Medicare participating
At a glance
- Medical school
- Perelman School of Med at the University of Pennsylvania (1975)
- Years since graduation
- 51
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 594
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1975Medical school: Perelman School of Med at the University of Pennsylvania
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Hematology & Oncology Physician primary
PA license MD018597E
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Hospital of Univ of Pennsylvania Philadelphia, PA
- Penn Presbyterian Medical Center Philadelphia, PA
- Chester County Hospital West Chester, PA
- Pennsylvania Hospital Philadelphia, PA
Medical groups
- University of Penn - Medical Group (3,505 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 594
- Services billed
- 2,093
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 873 | 442 |
| Established patient office or other outpatient visit, 40-54 minutes | 209 | 83 |
| New patient office or other outpatient visit, 60-74 minutes | 57 | 57 |
| New patient office or other outpatient visit, 45-59 minutes | 53 | 53 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 46 | 25 |
| Telephone medical discussion with physician, 21-30 minutes | 35 | 23 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 29 | 13 |
| Hospital discharge day management, 30 minutes or less | 15 | 14 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 12 | 12 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Eliquis (apixaban) Other prescribers in Philadelphia, PA | 75 |
| Hydroxyurea Other prescribers in Philadelphia, PA | 45 |
| Anastrozole Other prescribers in Philadelphia, PA | 44 |
| Lenalidomide | 42 |
| Xarelto (rivaroxaban) Other prescribers in Philadelphia, PA | 42 |
| Oxycodone Hcl Other prescribers in Philadelphia, PA | 33 |
| Butalbital-Acetaminophen-Caffe (butalb/acetaminophen/caffeine) Other prescribers in Philadelphia, PA | 29 |
| Genvoya (elviteg/cob/emtri/tenof alafen) | 28 |
| Prednisone Other prescribers in Philadelphia, PA | 26 |
| Tranexamic Acid | 24 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 2 companies reported 2 payments worth $39.94 in total to this clinician.
| Janssen Biotech, Inc. | $20.18 |
|---|---|
| Merck Sharp & Dohme LLC | $19.76 |
| Food and Beverage | $39.94 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.